Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions

Acute Respiratory FailureHypercoagulabilityFibrinolysis Shutdown

Interventions

DRUG

Alteplase

The enzyme tissue plasminogen activator that cleaves plasminogen to form plasmin.

Trial Locations (1)

RECRUITING

Intensive Care Unit, Liverpool Hospital, South Western Sydney Local Health District, Liverpool

All Listed Sponsors

lead

South West Sydney Local Health District

OTHER